In a recent eyeforpharma survey, 70% of respondents revealed that harnessing RWE is the greatest single answer to wider market access.
However, RWE can do so much more. In this free webinar, we will explore how, when used smartly, development, patient recruitment, label widening and discovery can all be transformed through intelligent use of RWD.
In particular, we will focus on how R&D’s productivity problems can be reduced significantly through accelerated development timelines and enhanced accuracy, by providing a new level of patient insight and understanding.
In this unique session we will expand your horizons, while accelerating your RWE investments in order that a wider variety of departments can enjoy the enhanced vision and decision-making that comes from RWD:
Global Head of RWD Collaborations, Genentech/Roche
Business Operations, Evidation Health
Director, Clinical Innovation, Pfizer